Ambrx Biopharma Inc. logo

Ambrx Biopharma Inc.

NYSE:AMAM

Overview | Financials
Company Name Ambrx Biopharma Inc.
Symbol AMAM
Currency USD
Price 28
Market Cap 1,772,097,600
Dividend Yield 0%
52-week-range 6.55 - 28.15
Industry Biotechnology
Sector Healthcare
CEO Mr. Daniel J. O'Connor J.D.
Website https://ambrx.com

An error occurred while fetching data.

About Ambrx Biopharma Inc.

Ambrx Biopharma Inc., a clinical-stage biologics company, discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. Its lead product candidate is ARX788, an anti-HER2 antibody-drug conjugate (ADC), which is investigated in various clinical trials for the treatment of breast cancer, gastric/gastroesophageal junction cancer, and other

Related Stocks

Sonida Senior Living, Inc. logo

Sonida Senior Living, Inc.

SNDA

26.92 USD

Enzo Biochem, Inc. logo

Enzo Biochem, Inc.

ENZ

1.12 USD

Vapotherm, Inc. logo

Vapotherm, Inc.

VAPO

2.16 USD

Annovis Bio, Inc. logo

Annovis Bio, Inc.

ANVS

7.87 USD

Sonendo, Inc. logo

Sonendo, Inc.

SONX

0.063 USD

Rafael Holdings, Inc. logo

Rafael Holdings, Inc.

RFL

1.51 USD

Financials

Numbers are in millions USD

Numbers are in millions USD